These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 27563818)
1. Cadherin-6 type 2, K-cadherin (CDH6) is regulated by mutant p53 in the fallopian tube but is not expressed in the ovarian surface. Karthikeyan S; Lantvit DD; Chae DH; Burdette JE Oncotarget; 2016 Oct; 7(43):69871-69882. PubMed ID: 27563818 [TBL] [Abstract][Full Text] [Related]
2. Loss of PAX8 in high-grade serous ovarian cancer reduces cell survival despite unique modes of action in the fallopian tube and ovarian surface epithelium. Rodgers LH; Ó hAinmhire E; Young AN; Burdette JE Oncotarget; 2016 May; 7(22):32785-95. PubMed ID: 27129161 [TBL] [Abstract][Full Text] [Related]
3. Both fallopian tube and ovarian surface epithelium are cells-of-origin for high-grade serous ovarian carcinoma. Zhang S; Dolgalev I; Zhang T; Ran H; Levine DA; Neel BG Nat Commun; 2019 Nov; 10(1):5367. PubMed ID: 31772167 [TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis reveals a role for PAX8 in peritoneal colonization of high grade serous ovarian cancer that can be targeted with micelle encapsulated thiostrepton. Hardy LR; Pergande MR; Esparza K; Heath KN; Önyüksel H; Cologna SM; Burdette JE Oncogene; 2019 Aug; 38(32):6003-6016. PubMed ID: 31296958 [TBL] [Abstract][Full Text] [Related]
5. Mutant p53 expression in fallopian tube epithelium drives cell migration. Quartuccio SM; Karthikeyan S; Eddie SL; Lantvit DD; Ó hAinmhire E; Modi DA; Wei JJ; Burdette JE Int J Cancer; 2015 Oct; 137(7):1528-38. PubMed ID: 25810107 [TBL] [Abstract][Full Text] [Related]
6. PAX2 function, regulation and targeting in fallopian tube-derived high-grade serous ovarian cancer. Modi DA; Tagare RD; Karthikeyan S; Russo A; Dean M; Davis DA; Lantvit DD; Burdette JE Oncogene; 2017 May; 36(21):3015-3024. PubMed ID: 27991925 [TBL] [Abstract][Full Text] [Related]
7. Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube. Yang J; Zhou Y; Ng SK; Huang KC; Ni X; Choi PW; Hasselblatt K; Muto MG; Welch WR; Berkowitz RS; Ng SW BMC Cancer; 2017 Jun; 17(1):422. PubMed ID: 28623900 [TBL] [Abstract][Full Text] [Related]
8. Genetic determinants of FOXM1 overexpression in epithelial ovarian cancer and functional contribution to cell cycle progression. Barger CJ; Zhang W; Hillman J; Stablewski AB; Higgins MJ; Vanderhyden BC; Odunsi K; Karpf AR Oncotarget; 2015 Sep; 6(29):27613-27. PubMed ID: 26243836 [TBL] [Abstract][Full Text] [Related]
9. PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma. Ghannam-Shahbari D; Jacob E; Kakun RR; Wasserman T; Korsensky L; Sternfeld O; Kagan J; Bublik DR; Aviel-Ronen S; Levanon K; Sabo E; Larisch S; Oren M; Hershkovitz D; Perets R Oncogene; 2018 Apr; 37(17):2213-2224. PubMed ID: 29379162 [TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles of ovarian low-grade serous carcinoma resemble those of fallopian tube epithelium. Qiu C; Lu N; Wang X; Zhang Q; Yuan C; Yan S; Dongol S; Li Y; Sun X; Sun C; Zhang Z; Zheng W; Kong B Gynecol Oncol; 2017 Dec; 147(3):634-641. PubMed ID: 28965696 [TBL] [Abstract][Full Text] [Related]
11. Activin A stimulates migration of the fallopian tube epithelium, an origin of high-grade serous ovarian cancer, through non-canonical signaling. Dean M; Davis DA; Burdette JE Cancer Lett; 2017 Apr; 391():114-124. PubMed ID: 28115208 [TBL] [Abstract][Full Text] [Related]
12. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors]. Wen J; Shi JL; Shen DH; Chen YX; Song QJ Zhonghua Bing Li Xue Za Zhi; 2012 Jul; 41(7):433-7. PubMed ID: 22932451 [TBL] [Abstract][Full Text] [Related]
13. The ovary is an alternative site of origin for high-grade serous ovarian cancer in mice. Kim J; Coffey DM; Ma L; Matzuk MM Endocrinology; 2015 Jun; 156(6):1975-81. PubMed ID: 25815421 [TBL] [Abstract][Full Text] [Related]
14. Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma. de Cristofaro T; Di Palma T; Soriano AA; Monticelli A; Affinito O; Cocozza S; Zannini M Oncotarget; 2016 Jul; 7(27):41929-41947. PubMed ID: 27259239 [TBL] [Abstract][Full Text] [Related]
15. PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation. Russo A; Czarnecki AA; Dean M; Modi DA; Lantvit DD; Hardy L; Baligod S; Davis DA; Wei JJ; Burdette JE Oncogene; 2018 Apr; 37(15):1976-1990. PubMed ID: 29367766 [TBL] [Abstract][Full Text] [Related]
16. Progestin Significantly Inhibits Carcinogenesis in the Mogp-TAg Transgenic Mouse Model of Fallopian Tube Cancer. Nelson OL; Rosales R; Turbov JM; Thaete LG; Cline JM; Rodriguez GC Cancer Prev Res (Phila); 2022 Feb; 15(2):75-86. PubMed ID: 34844992 [TBL] [Abstract][Full Text] [Related]
19. In vivo tumor growth of high-grade serous ovarian cancer cell lines. Mitra AK; Davis DA; Tomar S; Roy L; Gurler H; Xie J; Lantvit DD; Cardenas H; Fang F; Liu Y; Loughran E; Yang J; Sharon Stack M; Emerson RE; Cowden Dahl KD; V Barbolina M; Nephew KP; Matei D; Burdette JE Gynecol Oncol; 2015 Aug; 138(2):372-7. PubMed ID: 26050922 [TBL] [Abstract][Full Text] [Related]
20. [Origin of ovarian epithelial inclusions and its relationship with the development of low-grade serous carcinoma]. Xiang L; Li J; Wang LJ; Zheng WX; Kong BH Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):729-35. PubMed ID: 22321344 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]